Differential production of apoptosis-modulating proteins in patients with hypertrophic burn scar

Journal of Surgical Research

Volumn 75, Issue 1, 1998, Pages 74-80

  Wassermann, R J ^a   Polo, M ^b   Smith, P ^b   Wang, X ^b   Ko, F ^b   Robson, M C ^b  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Bay Pines VA Medical Center   (United States)

Author keywords

Apoptosis; Burns; Hypertrophic healing; Thermal injury

Indexed keywords

CYSTEINE PROTEINASE; FAS ANTIGEN; INTERLEUKIN CONVERTING ENZYME; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BURN SCAR; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTROPHIC SCAR; IMMUNOPEROXIDASE STAINING; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032519372     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5267     Document Type: Article

References (31)

1. Helm P. Burn rehabilitation: Dimensions of the problem. Clin. Plast. Surg. 19:1992;551-559.
2. Linares H. A. From wound to scar. Bums. 22:1996;339-352.
3. Linares H. A., Kischer C. W., Dobrkovsky N. I. The histiotypic organization of hypertrophic scar in human. J. Invest. Dermatol. 59:1972;323-331.
4. Linares H. A., Larson D. L. Early differential diagnosis between hypertrophic and normotrophic healing. J. Invest. Dermatol. 62:1974;514-516.
5. Linares H. A., Larson D. L. Proteoglycans and collagenase in hypertrophic scar formation. J. Plast. Reconstr. Surg. 62:1978;589-593.
6. What S. M., Whal L. M. Inflammation. Wound Healing, Biochemical and Clinical Aspects. 1992;Saunders, Philadelphia. p. 40-62.
7. Wahl S. M., Wahl L. M., McCarthy J. B. Lymphocyte mediated activation of fibroblast proliferation and collagen production. J. Immunol. 121:1978;942-946.
8. Kovacs E. J. Fibrogenic cytokines: The role of immune mediators in the development of scar tissue. Immunol. Today. 12:1991;17-23.
9. Vaux, D. Cory, S. Adams, J. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortilize pre B cells, Nature (London), 335, 440, 442.
10. Hockenberry, D. C. Nunez, C. Milliman, R. D. et al., Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death, Nature (London), 348, 334, 336.
11. Vaux D. L. Toward an understanding of the molecular mechanisms of physiological cell death. Proc. Natl. Acad. Sci. USA. 90:1993;786-789.
12. Reed J. C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1994;1-6.
13. Vaux D. L., Hawkins C. J. Analysis of the role of Bcl-2 in apoptosis. Immunol. Rev. 142:1994;127-139.
14. Trauth B. C., Kias C., Peters A. M. J. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science. 245:1989;301-303.
15. Yonehara S., Ishii A., Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1989;1747-1756.
16. Suda T., Takahashi T., Golstein P. Molecular cloning and expression of theFas. Cell. 75:1993;1169-1178.
17. Enari M., Hug H., Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature. 375:1995;78-81.
18. Los M., Van de Craen M., Penning L. Requirement of an ICE/CED-3 protease for Fas/APO-1 mediated apoptosis. Nature. 375:1995;81-83.
19. Abbas A. K. Die and let live: Eliminating dangerous lymphocytes. Cell. 84:1996;655-657.
20. Miura M., Zhu H., Rotelo R. Induction of apoptosis in fibroblasts by IL-1 beta converting enzyme, a mammalian homolog of theC. elegans. Cell. 75:1993;653-660.
21. Desmouliere A., Redard M., Darby I. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am. J. Pathol. 146:1995;56-66.
22. Garbin S., Pittet B., Montandon D. Covering by a flap induces apoptosis of granulation tissue fibroblasts and vascular cells. Wound Rep. Reg. 4:1996;244-251.
23. Darby I., Bisucci T., Hewitson T., MacLellan D. Apoptosis is increased in a model of diabetes-impaired wound healing in genetically diabetic mice. Int. J. Biochem. Cell Biol. 29:1997;191-200.
24. Su Y., Arnold F., Cherry G. Proliferation and apoptosis in chronic wounds. Wound Repair Regeneration. 4:1996;A141.
25. Brown D., Winston W., Greenhalgh D. G. Effects of topical application of growth factors on delayed apoptosis patterns in wounds of diabetic mice. Wound Repair Regeneration. 4:1996;A146.
26. Jurgensmeir J. M., Schitt C. P., Viesel E. Transforming growth factor β-treated normal fibroblasts eliminate transformed fibroblasts by induction of apoptosis. Cancer Res. 54:1994;393-398.
27. Ladin, L. Patel, D. McPhail, M. Dysregulated p53, bcl-2, and Fas Expression in Keloids, Boston, MA, Wound Healing Soc. 1996.
28. Kicher C. W. Comparative ultrastructure of hypertrophic scars and keloids. SEM/I. 1994;423-431.
29. Polo, M. Ko, F. Busillo, F. et al., Cytokine production in patients with hypertrophic scars, Burn Care Rehab.
30. Morgan C. J., Pledger W. J. Cohen I. K., Diegleman R., Linbald W. J. Wound Healing, Biochemical and Clinical Aspects. 1992;63-72 Saunders, Philadelphia.
31. Davidson J. M., Broadley K. N., Quaglino D. Reversal of the wound healing deficits in diabetic rats by combined basic fibroblastic growth factor and transforming growth factor B-1 therapy. Wound Rep. Reg. 5:1997;77-88.